Dr Reddy's Laboratories Debt to Equity Ratio 2006-2018 | RDY

Current and historical debt to equity ratio values for Dr Reddy's Laboratories (RDY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Dr Reddy's Laboratories debt/equity for the three months ending September 30, 2018 was 0.21.
Dr Reddy's Laboratories Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.38B $1.81B 0.21
2018-06-30 $0.38B $1.91B 0.20
2018-03-31 $0.39B $1.94B 0.20
2017-12-31 $0.38B $1.94B 0.20
2017-09-30 $0.38B $1.87B 0.21
2017-06-30 $0.38B $1.91B 0.20
2017-03-31 $0.08B $1.91B 0.04
2016-12-31 $0.08B $1.78B 0.05
2016-09-30 $0.16B $1.73B 0.09
2016-06-30 $0.16B $1.69B 0.10
2016-03-31 $0.16B $1.94B 0.08
2015-12-31 $0.16B $1.94B 0.08
2015-09-30 $0.16B $1.86B 0.09
2015-06-30 $0.19B $1.87B 0.10
2015-03-31 $0.23B $1.79B 0.13
2014-12-31 $0.26B $1.67B 0.16
2014-09-30 $0.29B $1.60B 0.18
2014-06-30 $0.32B $1.61B 0.20
2014-03-31 $0.35B $1.51B 0.23
2013-12-31 $0.37B $1.38B 0.27
2013-09-30 $0.40B $1.25B 0.32
2013-06-30 $0.23B $1.26B 0.19
2013-03-31 $0.23B $1.34B 0.17
2012-12-31 $0.32B $1.24B 0.26
2012-09-30 $0.32B $1.19B 0.27
2012-06-30 $0.31B $1.07B 0.29
2012-03-31 $0.32B $1.13B 0.28
2011-12-31 $0.32B $0.98B 0.32
2011-09-30 $0.11B $0.98B 0.11
2011-06-30 $0.12B $1.10B 0.11
2011-03-31 $0.12B $1.03B 0.11
2010-12-31 $0.01B $1.07B 0.01
2010-09-30 $0.05B $0.97B 0.05
2010-06-30 $0.09B $0.97B 0.09
2010-03-31 $0.12B $0.96B 0.13
2009-12-31 $0.15B $0.87B 0.17
2009-09-30 $0.17B $0.95B 0.18
2009-06-30 $0.19B $0.94B 0.20
2009-03-31 $0.20B $0.83B 0.24
2008-12-31 $0.23B $1.07B 0.22
2008-09-30 $0.26B $1.07B 0.24
2008-06-30 $0.30B $1.15B 0.26
2008-03-31 $0.32B $1.18B 0.27
2007-12-31 $0.30B $1.12B 0.27
2007-09-30 $0.31B $1.14B 0.27
2007-06-30 $0.31B $1.06B 0.29
2007-03-31 $0.42B $0.97B 0.43
2006-12-31 $0.35B $0.87B 0.40
2006-09-30 $0.45B $0.58B 0.78
2006-06-30 $0.47B $0.52B 0.90
2006-03-31 $0.47B $0.50B 0.94
2005-12-31 $0.00B $0.50B 0.00
2005-09-30 $0.00B $0.50B 0.00
2005-06-30 $0.00B $0.49B 0.00
2005-03-31 $0.00B $0.48B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.845B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.630B 9.04
Teva Pharmaceutical Industries (TEVA) Israel $22.371B 6.85
Mylan (MYL) United Kingdom $17.841B 7.35
Bausch Health Cos (BHC) Canada $8.219B 5.95
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.568B 4.28
Supernus Pharmaceuticals (SUPN) United States $2.211B 20.95
Amphastar Pharmaceuticals (AMPH) United States $0.945B 102.55
Akorn (AKRX) United States $0.851B 0.00
Homology Medicines (FIXX) United States $0.720B 0.00
Assembly Biosciences (ASMB) United States $0.622B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.439B 0.00
Voyager Therapeutics (VYGR) United States $0.377B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Teligent (TLGT) United States $0.117B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.089B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Acasti Pharma (ACST) Canada $0.053B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00